Quantcast
Last updated on May 25, 2013 at 9:20 EDT

Latest irritation Stories

2013-03-21 23:02:29

Bescot Healthcare Canada announces the Canadian launch of Zestica Moisture™, a natural feeling, non-hormonal personal Moisturizing Hydrogel for Menopausal and Post-Menopausal women to relieve the symptoms of Vaginal Dryness. Toronto, Canada (PRWEB) March 21, 2013 A new vaginal “natural feel” moisturizing hydrogel for women is now available in Canada. Zestica Moisture™ is formulated specifically to provide rapid and lasting relief from vaginal dryness for Menopausal and...

2011-05-16 15:38:00

ARLINGTON, Va., May 16, 2011 /PRNewswire/ -- With the summer pool season just weeks away, swimmers will no longer smell like chlorine. Used after swimming, SwimSpray eliminates chlorine odor and irritation from hair and skin. Invented by a swimmer, SwimSpray is 100% natural with Vitamin C. "I was ready to give up swimming because of the post-workout chlorine smell I always had," says Andrew Chadeayne, PhD and inventor of SwimSpray. After trying three or four other products in the market,...

2010-09-15 07:53:00

SHELTON, Conn., Sept. 15 /PRNewswire/ -- Officials at Edge® shave gel are announcing a new campaign designed to stamp out irritation, one tweet at a time. The Edge Irritation Solutions campaign provides real time irritation relief to people voicing their frustrations on Twitter. Irritation Solutions Team staffers, using the Edge Twitter handle @EdgeShaveZone, monitor for annoyed tweeters and then offer a helping hand in the form of prizes, gift cards or other items that might lend a...

2010-07-27 08:38:00

SHELTON, Conn., July 27 /PRNewswire/ -- A new study measuring everyday irritations like heat, traffic and household pests ranks major southern cities among the most irritated in the nation. Atlanta (No. 1), Houston (No. 2), Washington DC (No. 3) and Baltimore (No. 4) ranked the highest in irritating factors, while predominantly northern cities like Rochester (No. 50), Milwaukee (No. 49), Minneapolis (No. 48), Buffalo (No. 47), and Tucson (No. 46), the arid outlier, ranked the lowest. To...

2010-06-23 11:43:00

MORRIS PLAINS, N.J., June 23 /PRNewswire/ -- Now irritated, red eyes can get the fast, effective relief they need with the launch of NEW VISINE® Maximum Redness Relief Formula. Plus, the free new VISINE® Red Eye Remover Application lets iPhone® and iPod® Touch users eliminate red eye from their photos in moments. New! VISINE® Maximum Redness Relief Formula features a fast acting redness reliever that GETS THE RED OUT(TM) in seconds, coupled with the exclusive...

2009-08-06 06:00:00

NEW YORK, Aug. 6 /PRNewswire/ -- Lumixyl(TM) a non-toxic, non-irritating, synthetic peptide technology shown to significantly help improve the appearance of unwanted discoloration, age spots, sun spots and uneven skin tone is now available through select physicians to help their patients achieve picture perfect skin. A hydroquinone alternative, this new cosmeceutical skin brightening cream can be found in leading physician offices for $120 per 1 ounce pump. To view the Multimedia News...

2009-02-05 12:34:51

Indoor water parks require special attention to reduce and prevent work-related risk of eye and respiratory irritation, U.S. health officials say. The Centers for Disease Control and Prevention's Mortality and Morbidity Weekly Report said the National Institute for Occupational Safety and Health investigated reports of eye and respiratory irritation among lifeguards at an indoor hotel water park. Investigators used a multipronged approach which included environmental sampling,...

2008-09-04 09:00:08

ANN ARBOR, Mich., Sept. 4 /PRNewswire/ -- QuatRx Pharmaceuticals, a privately-held biopharmaceutical company focused on development and commercialization of compounds to treat endocrine, metabolic and cardiovascular disorders, today announced that it has initiated a second Phase 3 clinical trial of Ophena(TM) (ospemifene tablets), the company's estrogen-free oral therapy in development for the treatment of vaginal symptoms associated with menopause. The study is the second pivotal Phase 3...